MUSCLE INVASIVE BLADDER CANCER (MIBC)
Clinical trials for MUSCLE INVASIVE BLADDER CANCER (MIBC) explained in plain language.
Never miss a new study
Get alerted when new MUSCLE INVASIVE BLADDER CANCER (MIBC) trials appear
Sign up with your email to follow new studies for MUSCLE INVASIVE BLADDER CANCER (MIBC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising combo aims to shrink bladder tumors before surgery
Disease control Not yet recruitingThis study tests whether combining two drugs (trastuzumab rezetecan and camrelizumab) before surgery can improve outcomes for people with a certain type of muscle-invasive bladder cancer (HER2-positive). About 44 adults will receive the treatment to see if it helps eliminate canc…
Matched conditions: MUSCLE INVASIVE BLADDER CANCER (MIBC)
Phase: PHASE2 • Sponsor: Sheng Tai • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New drug duo aims to wipe out bladder tumors before surgery
Disease control Not yet recruitingThis study tests whether giving two drugs (trastuzumab rezetecan and adebrelimab) before surgery can eliminate or shrink tumors in people with a specific type of muscle-invasive bladder cancer (HER2-positive). About 58 adults will receive the combination, then have their bladder …
Matched conditions: MUSCLE INVASIVE BLADDER CANCER (MIBC)
Phase: PHASE2 • Sponsor: Harbin Medical University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Gut bacteria may help bladder cancer patients avoid surgery
Disease control Not yet recruitingThis study tests whether adding a probiotic (Clostridium butyricum) to a combination of targeted therapy (Disitamab Vedotin) and immunotherapy (Toripalimab) can help preserve the bladder in people with muscle-invasive bladder cancer who cannot take the chemotherapy drug cisplatin…
Matched conditions: MUSCLE INVASIVE BLADDER CANCER (MIBC)
Phase: PHASE2 • Sponsor: chenxu • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New combo aims to save bladders in cancer fight
Disease control Not yet recruitingThis study tests whether two drugs, Vedisertib and Toripalimab, can shrink muscle-invasive bladder cancer so patients can keep their bladder. About 59 adults with early-stage cancer will receive the drugs in cycles, with regular checks to see if the cancer disappears. If it does,…
Matched conditions: MUSCLE INVASIVE BLADDER CANCER (MIBC)
Phase: PHASE2 • Sponsor: Qilu Hospital of Shandong University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Bladder preservation: a viable alternative to radical surgery?
Knowledge-focused Not yet recruitingThis registry study follows bladder cancer patients who, after receiving systemic therapy, choose not to undergo bladder removal (cystectomy) or radiotherapy. The goal is to collect data on their outcomes, such as metastasis-free survival, to better understand which patients migh…
Matched conditions: MUSCLE INVASIVE BLADDER CANCER (MIBC)
Sponsor: Heinrich-Heine University, Duesseldorf • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
Microscopic clues may forecast bladder Cancer's next move
Knowledge-focused Not yet recruitingThis study examines two microscopic details in bladder cancer tumors—how deep early cancer cells have invaded and whether small clusters of cells are present at the tumor's edge. Researchers will look at tissue samples from 100 patients to see if these features can predict if the…
Matched conditions: MUSCLE INVASIVE BLADDER CANCER (MIBC)
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC